摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (S)-2-acetamido-3-(4-(benzyloxy)phenyl)propanoate | 39613-68-8

中文名称
——
中文别名
——
英文名称
methyl (S)-2-acetamido-3-(4-(benzyloxy)phenyl)propanoate
英文别名
methyl (2S)-2-acetamido-3-(4-phenylmethoxyphenyl)propanoate
methyl (S)-2-acetamido-3-(4-(benzyloxy)phenyl)propanoate化学式
CAS
39613-68-8
化学式
C19H21NO4
mdl
——
分子量
327.38
InChiKey
AQQXVKQWGGPPHH-SFHVURJKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    523.1±45.0 °C(Predicted)
  • 密度:
    1.157±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    24
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (S)-2-acetamido-3-(4-(benzyloxy)phenyl)propanoate 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 N-乙酰-L-酪氨酸甲酯
    参考文献:
    名称:
    Preparation of diaryl ethers from tyrosine or 4-hydroxyphenylglycine using organomanganese chemistry
    摘要:
    DOI:
    10.1021/jo00361a043
  • 作为产物:
    描述:
    Boc-L-酪氨酸甲酯 在 sodium carbonate 、 potassium carbonate三氟乙酸 、 sodium iodide 作用下, 以 二氯甲烷丙酮 为溶剂, 反应 15.0h, 生成 methyl (S)-2-acetamido-3-(4-(benzyloxy)phenyl)propanoate
    参考文献:
    名称:
    Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
    摘要:
    A series of novel L-tyrosine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and histone deacetylase 8 (HDAC-8). The results showed that these L-tyrosine derivatives exhibited inhibitory profiles against MMP-2 and HDAC-8. The compounds 6h (IC50 = 0.013 +/- 0.001 mu M) and 6j (IC50 = 0.017 +/- 0.001 mu M) were equal potent MMP-2 inhibitors to the positive control NNGH (IC50 = 0.014 +/- 0.001 mu M). As for HDAC-8 inhibition, some of the hydroxamate compounds, such as 6d (IC50 = 3.6 +/- 0.2 mu M) and 6c (IC50 = 5.8 +/- 0.5 mu M), were equal potent to the positive control SAHA (IC50 = 1.6 +/- 0.1 mu M). Structure-activity relationships were also briefly discussed. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.014
点击查看最新优质反应信息

文献信息

  • Easy access to drug building-blocks through benzylic C–H functionalization of phenolic ethers by photoredox catalysis
    作者:Tobias Brandhofer、Martin Stinglhamer、Volker Derdau、María Méndez、Christoph Pöverlein、Olga García Mancheño
    DOI:10.1039/d1cc01756j
    日期:——
    A visible light-mediated photocatalyzed C–C-bond forming method for the benzylic C–H functionalization of phenolether containing synthetic building blocks based on a radical-cation/deprotonation strategy is reported. This method allows the mild, selective generation of benzyl radicals in phenolic complex molecules and drug-like compounds, providing new entries in synthetic and medicinal chemistry.
    报道了一种基于自由基阳离子/去质子化策略的可见光介导的光催化 C - C 键形成方法,用于含合成结构单元的苯酚醚的苄基 C-H 官能化。该方法允许在酚类复合物分子和类药物化合物中温和、选择性地生成苄基,为合成和药物化学提供了新的入口。
  • Proline-rich proteins—deriving a basis for residue-based selectivity in polyphenolic binding
    作者:A. K. Croft、M. K. Foley
    DOI:10.1039/b800365c
    日期:——
    1H NMR titration experiments have been used to establish that minimal proline-based models show enhanced binding selectivity towards phenol in CDCl3, relative to other similarly protected amino acid residues. Cooperative binding effects appear to play a role, with sarcosine models affording binding constants to phenol intermediate to those obtained from proline models and other amino acid models. The mechanism for binding, based on DFT calculations and the application of Hunter's molecular recognition toolbox model, cannot be solely attributed to hydrogen bond strength, and appears to be mediated through C–H-π bonds and the rotational freedom of the amide substrate.
    1H NMR 滴定实验证明,相对于其他类似的受保护氨基酸残基,基于脯氨酸的最小模型在 CDCl3 中对苯酚的结合选择性更强。协同结合效应似乎在其中发挥了作用,肌氨酸模型与苯酚的结合常数介于脯氨酸模型和其他氨基酸模型得到的结合常数之间。根据 DFT 计算和亨特分子识别工具箱模型的应用,结合机制不能完全归因于氢键强度,而似乎是通过 CâH-Ï 键和酰胺底物的旋转自由度介导的。
  • 10.1021/acs.joc.4c00988
    作者:Bag, Raghunath、Sharma, Nagendra K.
    DOI:10.1021/acs.joc.4c00988
    日期:——
    a Pd-catalyzed picolinamide-directed site-selective C(sp2)–H sulfonylation of amino acids and peptides with sodium sulfinates in moderate to good yields. Sulfonylation of levodopa and dopamine drug molecules and late-stage directed peptide sulfonylation are studied for the first time. Broad substrate scope having various functionalities, late-stage drug modifications, and various post synthetic utilities
    本报告描述了 Pd 催化的吡啶甲酰胺定向位点选择性 C(sp2)-H 氨基酸和肽与亚磺酸钠的磺酰化反应,产率中等至良好。首次研究了左旋多巴和多巴胺药物分子的磺酰化以及晚期定向肽磺酰化。潜在的优势包括具有各种功能的广泛底物范围、后期药物修饰以及各种合成后实用程序,如硫属化、溴化、烯化和芳基化。
  • Preparation of diaryl ethers from tyrosine or 4-hydroxyphenylglycine using organomanganese chemistry
    作者:Anthony J. Pearson、Paul R. Bruhn、Shih Ying Hsu
    DOI:10.1021/jo00361a043
    日期:1986.5
  • Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
    作者:Xian-Chao Cheng、Run-Ling Wang、Zhen-Ke Dong、Jing Li、Yao-Yuan Li、Rong-Rong Li
    DOI:10.1016/j.bmc.2012.08.014
    日期:2012.10
    A series of novel L-tyrosine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and histone deacetylase 8 (HDAC-8). The results showed that these L-tyrosine derivatives exhibited inhibitory profiles against MMP-2 and HDAC-8. The compounds 6h (IC50 = 0.013 +/- 0.001 mu M) and 6j (IC50 = 0.017 +/- 0.001 mu M) were equal potent MMP-2 inhibitors to the positive control NNGH (IC50 = 0.014 +/- 0.001 mu M). As for HDAC-8 inhibition, some of the hydroxamate compounds, such as 6d (IC50 = 3.6 +/- 0.2 mu M) and 6c (IC50 = 5.8 +/- 0.5 mu M), were equal potent to the positive control SAHA (IC50 = 1.6 +/- 0.1 mu M). Structure-activity relationships were also briefly discussed. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物